Effect of estramustine, etoposide, and taxol on prostate cancer cell growth in vitro and in vivo

By Pienta K.J.   Naik H.   Lehr J.E.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Implications of circulating chromogranin A in prostate cancer

By Hirano Daisaku   Minei Sadatsugu   Sugimoto Shuji   Yamaguchi Kenya   Yoshikawa Tetsuo   Hachiya Takahiko   Kawata Nozomu   Yoshida Toshio   Takahashi Satoru  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 4, 2007-09 ,pp. : 297-301

Informa Healthcare

Access to resources Recommend Favorite

Chromogranin a in monitoring response and prognosis of hormone refractory prostate cancer

By Lapini A.   Meliani E.   Semi S.   Masieri L.   Farina U.   Corvino C.   Carini M.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 189-189

Elsevier

Access to resources Recommend Favorite

Angiogenesis and Prostate Cancer: In vivo and In vitro Expression of Angiogenesis Factors by Prostate Cancer Cells

By Ferrer F.A.   Miller L.J.   Andrawis R.I.   Kurtzman S.H.   Albertsen P.C.   Laudone V.P.   Kreutzer D.L.  

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 161-167

Elsevier

Access to resources Recommend Favorite

The Survival Effect of Prolactin on PC3 Prostate Cancer Cells

By Ruffion A.   Al-Sakkaf K.A.   Brown B.L.   Eaton C.L.   Hamdy F.C.   Dobson P.R.M.  

European Urology, Vol. 43, Iss. 3, 2003-03 ,pp. : 301-308

Elsevier

Access to resources Recommend Favorite